Recent Updates
Recently added Catalysts
ARGX

arGEN-X initiates Phase Ib study of ARGX-111 in cancer

Monday, September 16, 2013 1 min read
Key Takeaway: arGEN-X initiates Phase Ib study of ARGX-111 in cancer

Full Press Release Details

arGEN-X initiates Phase Ib study of ARGX-111 in cancer.
Tags: ARGX Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Sep 16, 2013